Prim, S.A. — Cyborg Score 6/10

Strategic Profile

Prim is a vertically-integrated specialised company which supplies innovative and proven technology to the healthcare sector, with strong teamwork culture, agile team, and technical expertise, backed by a strong financial position. The company operates PrimAcademy, an offline and digital training platform, differentiating itself through customer education and engagement.

Cyborg Score Rationale

Revenue grew 7.73% in 2024 to €233.36 million, demonstrating market traction. The company maintains healthy balance sheet metrics with current ratio of 2.23 and ROE of 9.14%. However, earnings declined and profitability margins remain modest for healthcare manufacturing.

Top Insights

• 2024 revenue reached €233.36 million (+7.73% YoY), showing consistent organic growth
• Listed on Spanish Stock Exchange since 1985, demonstrating decades of market stability
• Diversified into real estate through Inmobiliaria Catharsis SA subsidiary, providing non-core revenue diversification
• Beta of 0.59 indicates lower price volatility than market average, suggesting defensive characteristics

Named Competitors

• Prosthetic and Orthotic Solutions — Global orthopedic and prosthetic devices manufacturer
• Orthopaedic Technology — International leader in orthopedic prosthetics and mobility solutions
• Medical Device Distribution — Local medical supply and orthopedic distribution networks

Recent Developments

• (May 2025) Market cap approximately $196 million USD with 958 employees
• (2024) Revenue of €233.36 million (+7.73% growth), earnings of €10.92 million (-13.83%)
• (2025) Trading at €13.50 with neutral technical signals; company expanding international healthcare sector presence

Open the full interactive Prim, S.A. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.